ZHONGZHIPHARM (03737) announced its interim results, with a profit attributable to shareholders of 9.116 million yuan, an increase of 3.79% year-on-year.

date
19:30 26/08/2026
avatar
GMT Eight
China Pharmaceutical Industry (03737) announced its interim results for the six months ending June 30, 2026, with revenue of 790 million yuan (RMB, the same hereinafter), a year-on-year decrease of 10.28%; the profit attributable to equity holders of the parent company was 9.116 million yuan, an increase of 3.79% year-on-year; basic earnings per share were 1.1 cents.
ZHONGZHIPHARM (03737) announced its interim results for the six months ended June 30, 2026, with revenue of 790 million yuan (RMB, the same below), a year-on-year decrease of 10.28%; profit attributable to equity holders of the parent company was 9.116 million yuan, a year-on-year increase of 3.79%; basic earnings per share were 1.1 cents.